Meredith McKean, MD, MPH, discusses the background and goals from the recent long-term follow-up of a phase 1 study evaluating the combination of fianlimab and cemiplimab in advanced melanoma.

STOCKHOLM: Arcam AB chief executive officer Magnus Rene says the Swedish maker of 3D printers may soon have trouble keeping up with orders as airplane and engine makers start using the technology ...